Indeed, SOCS1 constitutive expression has been observed in patients with CML [189], in agreement with the reported hypomethylation of this gene [190], and was correlated with poor response to IFNα treatment, possibly due to a direct effect on receptor signaling [189]. This evidence concerns the gene IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive.